Skip to main content
Premium Trial:

Request an Annual Quote

Mike Grey, Robert Franza

Premium

Structural Genomix of San Diego has appointed Mike Grey, formerly president and CEO of Trega Biosciences, as chief business officer and a member of its board of directors. Grey will be responsible for the business, financial, and legal functions of SGX.

Robert Franza, founder and director of the Cell Systems Initiative at the University of Washington School of Medicine, has joined the advisory board of Seattle-based technology incubator Stratos Product Development.

“Dr. Franza’s exposure to the latest research in molecular biotechnology gives us insight that is rather extraordinary for a product development firm,” said Al Stephan, Stratos CEO.

Filed under

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.